In comparison, patients with osteosarcoma who express a high level of SIRT6 exhibit malignant clinical features and have a worse survival rate, with in vitro experiments indicating that SIRT6 overexpression aided MG63 cell motility and invasion [5]. Here, SIRT6 is linked to osteosarcoma.